Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
First Affiliated Hospital of Wenzhou Medical University
Fudan University
Centre Paul Strauss
Emory University
Fudan University
Shanghai Tongji Hospital, Tongji University School of Medicine
Fudan University
Replimune Inc.
Children's Oncology Group
Herlev Hospital
M.D. Anderson Cancer Center
IFOM ETS - The AIRC Institute of Molecular Oncology
IFOM ETS - The AIRC Institute of Molecular Oncology
Sichuan University
National Health Research Institutes, Taiwan
NRG Oncology
Tempus AI
Tempus AI
Centre Leon Berard
Hansung University
Latin American Cooperative Oncology Group
Peking Union Medical College Hospital
Fujian Medical University
Zhejiang University
AIDS Malignancy Consortium
Changhai Hospital
Zhejiang Cancer Hospital
Chinese PLA General Hospital
Federation Francophone de Cancerologie Digestive
Fudan University
Zhejiang University
Peking University Third Hospital
Zhujiang Hospital
Shanghai Zhongshan Hospital
Geneplus-Beijing Co. Ltd.
Cabrini Health
Rigshospitalet, Denmark
Peking Union Medical College Hospital
Jinling Hospital, China
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Peking Union Medical College Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Fudan University
University Health Network, Toronto
RenJi Hospital
Oslo University Hospital
Oslo University Hospital